PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood

Kris Ann P. Schultz, Surya P. Rednam, Junne Kamihara, Leslie Doros, Maria Isabel Achatz, Jonathan D. Wasserman, Lisa R. Diller, Laurence Brugieres, Harriet Druker, Katherine A. Schneider, Rose B. McGee, and William D. Foulkes


[embeddoc url=”/wp-content/uploads/2018/05/PTEN-DICER1-FH-and-Their-Associated-Tumor-Susceptibility-Syndromes-Clinical-Features-Genetics-and-Surveillance-Recommendations-in-Childhood.pdf” download=”all”]

Previous articleFrequent Gastrointestinal Polyps and Colorectal Adenocarcinomas in a Prospective Series of PTEN Mutation Carriers
Next articleAmerican Cancer Society Interviews PTEN Foundation President Kristin Anthony
The PTEN Hamartoma Tumor Syndrome Foundation was founded to find treatments or therapies for PTEN Syndromes by funding research, providing PHTS education, supporting patients, and by raising awareness. PHTS includes Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), PTEN-related Proteus syndrome (PS), and Proteus-like syndrome.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.